• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板与脓毒症多器官衰竭。

Platelets and Multi-Organ Failure in Sepsis.

机构信息

Department of Medical Science, University of Turin, 10126 Turin, Italy.

出版信息

Int J Mol Sci. 2017 Oct 20;18(10):2200. doi: 10.3390/ijms18102200.

DOI:10.3390/ijms18102200
PMID:29053592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5666881/
Abstract

Platelets have received increasing attention for their role in the pathophysiology of infectious disease, inflammation, and immunity. In sepsis, a low platelet count is a well-known biomarker for disease severity and more recently authors have focused their attention on the active role of platelets in the pathogenesis of multi-organ failure. Septic shock is characterised by a dysregulated inflammatory response, which can impair the microcirculation and lead to organ injury. Being at the crossroads between the immune system, clotting cascade, and endothelial cells, platelets seem to be an appealing central mediator and possible therapeutic target in sepsis. This review focuses on the pathogenic role of platelets in septic organ dysfunction in humans and animal models.

摘要

血小板在感染性疾病、炎症和免疫的病理生理学中的作用受到越来越多的关注。在脓毒症中,血小板计数低是疾病严重程度的一个众所周知的生物标志物,最近作者们还将注意力集中在血小板在多器官衰竭发病机制中的积极作用上。脓毒性休克的特征是炎症反应失调,这会损害微循环并导致器官损伤。血小板位于免疫系统、凝血级联和内皮细胞之间的交汇点,似乎是脓毒症中一个有吸引力的中心介质和可能的治疗靶点。这篇综述重点介绍了血小板在人类和动物模型脓毒症器官功能障碍中的致病作用。

相似文献

1
Platelets and Multi-Organ Failure in Sepsis.血小板与脓毒症多器官衰竭。
Int J Mol Sci. 2017 Oct 20;18(10):2200. doi: 10.3390/ijms18102200.
2
The role of platelets in sepsis.血小板在脓毒症中的作用。
Thromb Haemost. 2014 Oct;112(4):666-77. doi: 10.1160/TH14-02-0126. Epub 2014 Jun 26.
3
Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure.脓毒症或多器官功能衰竭患者血小板的激活及其与白细胞的相互作用
Eur J Clin Invest. 1995 Nov;25(11):843-51. doi: 10.1111/j.1365-2362.1995.tb01694.x.
4
Severity of multiple organ failure (MOF) but not of sepsis correlates with irreversible platelet degranulation.多器官功能衰竭(MOF)的严重程度而非败血症的严重程度与不可逆的血小板脱颗粒相关。
Infection. 1995 Jan-Feb;23(1):16-23. doi: 10.1007/BF01710051.
5
International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.国际血栓与止血学会显性弥散性血管内凝血评分可预测脓毒症患者的器官功能障碍和死亡率。
Blood Coagul Fibrinolysis. 2006 Sep;17(6):445-51. doi: 10.1097/01.mbc.0000240916.63521.2e.
6
Platelet and leukocyte activation correlate with the severity of septic organ dysfunction.血小板和白细胞活化与脓毒症器官功能障碍的严重程度相关。
Shock. 2002 Apr;17(4):263-8. doi: 10.1097/00024382-200204000-00004.
7
Prospectively validated predictions of shock and organ failure in individual septic surgical patients: the Systemic Mediator Associated Response Test.前瞻性验证个体脓毒症手术患者休克和器官衰竭的预测:全身介质相关反应试验
Crit Care. 2000;4(5):319-26. doi: 10.1186/cc715. Epub 2000 Sep 8.
8
The role of platelets in sepsis: A review.血小板在脓毒症中的作用:综述。
Biomol Biomed. 2024 Jan 18;24(4):741-752. doi: 10.17305/bb.2023.10135.
9
Elevated selectin levels after severe trauma: a marker for sepsis and organ failure and a potential target for immunomodulatory therapy.严重创伤后选择素水平升高:脓毒症和器官衰竭的标志物及免疫调节治疗的潜在靶点
J Trauma. 1996 Oct;41(4):653-62. doi: 10.1097/00005373-199610000-00010.
10
Hemostasis and endothelial damage during sepsis.脓毒症期间的止血与内皮损伤。
Dan Med J. 2015 Aug;62(8):B5135.

引用本文的文献

1
Bacteriological profile and antimicrobial resistance in sepsis cases in intensive care units in Lubumbashi: challenges and perspectives.卢本巴希重症监护病房脓毒症病例的细菌学特征及抗菌药物耐药性:挑战与展望
Ann Clin Microbiol Antimicrob. 2025 Jul 16;24(1):42. doi: 10.1186/s12941-025-00811-w.
2
Impact of antiplatelet therapy on outcomes of sepsis: A systematic review and meta-analysis.抗血小板治疗对脓毒症结局的影响:一项系统评价与荟萃分析。
PLoS One. 2025 Apr 29;20(4):e0322293. doi: 10.1371/journal.pone.0322293. eCollection 2025.
3
Dynamic neutrophil-to-lymphocyte-platelet ratio trajectories predict 30-day and 1-year mortality in sepsis: a retrospective cohort study based on MIMIC-IV 2.2.动态中性粒细胞与淋巴细胞-血小板比率轨迹预测脓毒症30天和1年死亡率:一项基于MIMIC-IV 2.2的回顾性队列研究
BMC Infect Dis. 2025 Apr 24;25(1):594. doi: 10.1186/s12879-025-10987-3.
4
Sepsis and post-sepsis syndrome: a multisystem challenge requiring comprehensive care and management-a review.脓毒症和脓毒症后综合征:一项需要综合护理与管理的多系统挑战——综述
Front Med (Lausanne). 2025 Apr 8;12:1560737. doi: 10.3389/fmed.2025.1560737. eCollection 2025.
5
C-reactive protein to platelet ratio as an early biomarker in differentiating neonatal late-onset sepsis in neonates with pneumonia.C反应蛋白与血小板比值作为鉴别新生儿肺炎合并新生儿晚发性败血症的早期生物标志物
Sci Rep. 2025 Mar 28;15(1):10760. doi: 10.1038/s41598-025-94845-x.
6
Clinical validation and optimization of machine learning models for early prediction of sepsis.用于脓毒症早期预测的机器学习模型的临床验证与优化
Front Med (Lausanne). 2025 Feb 5;12:1521660. doi: 10.3389/fmed.2025.1521660. eCollection 2025.
7
Recent Advances in Pathogenesis and Anticoagulation Treatment of Sepsis-Induced Coagulopathy.脓毒症诱导的凝血病发病机制及抗凝治疗的最新进展
J Inflamm Res. 2025 Jan 18;18:737-750. doi: 10.2147/JIR.S495223. eCollection 2025.
8
The Correlation of Hemostatic Parameters with the Development of Early Sepsis-Associated Encephalopathy. A Retrospective Observational Study.止血参数与早期脓毒症相关性脑病发生的相关性。一项回顾性观察研究。
J Crit Care Med (Targu Mures). 2024 Oct 31;10(4):329-336. doi: 10.2478/jccm-2024-0040. eCollection 2024 Oct.
9
Biomarkers of sepsis-induced coagulopathy: diagnostic insights and potential therapeutic implications.脓毒症诱导的凝血病的生物标志物:诊断见解及潜在治疗意义
Ann Intensive Care. 2025 Jan 17;15(1):12. doi: 10.1186/s13613-025-01434-2.
10
Inference and analysis of cell-cell communication of non-myeloid circulating cells in late sepsis based on single-cell RNA-seq.基于单细胞RNA测序的晚期脓毒症非髓系循环细胞间细胞通讯的推断与分析
IET Syst Biol. 2024 Dec;18(6):218-226. doi: 10.1049/syb2.12109. Epub 2024 Nov 22.

本文引用的文献

1
Management of Sepsis and Septic Shock.脓毒症和脓毒性休克的管理
JAMA. 2017 Feb 28;317(8):847-848. doi: 10.1001/jama.2017.0131.
2
AspiriN To Inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol.阿司匹林抑制脓毒症(抗脓毒症)随机对照试验方案。
BMJ Open. 2017 Jan 20;7(1):e013636. doi: 10.1136/bmjopen-2016-013636.
3
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.氢化可的松、维生素C和硫胺素治疗严重脓毒症和脓毒性休克:一项前后对照的回顾性研究。
Chest. 2017 Jun;151(6):1229-1238. doi: 10.1016/j.chest.2016.11.036. Epub 2016 Dec 6.
4
Hemodynamic coherence in sepsis.脓毒症中的血流动力学相干性。
Best Pract Res Clin Anaesthesiol. 2016 Dec;30(4):453-463. doi: 10.1016/j.bpa.2016.10.009. Epub 2016 Nov 5.
5
The Dynamics of Platelet Activation during the Progression of Streptococcal Sepsis.链球菌败血症进展过程中血小板激活的动力学
PLoS One. 2016 Sep 22;11(9):e0163531. doi: 10.1371/journal.pone.0163531. eCollection 2016.
6
Platelets and coagulation in infection.感染中的血小板与凝血
Clin Transl Immunology. 2016 Jul 8;5(7):e89. doi: 10.1038/cti.2016.39. eCollection 2016 Jul.
7
Effect of Antiplatelet Therapy on Acute Respiratory Distress Syndrome and Mortality in Critically Ill Patients: A Meta-Analysis.抗血小板治疗对危重症患者急性呼吸窘迫综合征及死亡率的影响:一项荟萃分析
PLoS One. 2016 May 16;11(5):e0154754. doi: 10.1371/journal.pone.0154754. eCollection 2016.
8
Effect of Aspirin on Development of ARDS in At-Risk Patients Presenting to the Emergency Department: The LIPS-A Randomized Clinical Trial.阿司匹林对急诊科有ARDS风险患者ARDS发生的影响:LIPS-A随机临床试验
JAMA. 2016 Jun 14;315(22):2406-14. doi: 10.1001/jama.2016.6330.
9
Blockade of Thrombopoietin Reduces Organ Damage in Experimental Endotoxemia and Polymicrobial Sepsis.血小板生成素的阻断可减轻实验性内毒素血症和多微生物脓毒症中的器官损伤。
PLoS One. 2016 Mar 10;11(3):e0151088. doi: 10.1371/journal.pone.0151088. eCollection 2016.
10
Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients.血小板减少症与危重病脓毒症患者中失调的宿主反应有关。
Blood. 2016 Jun 16;127(24):3062-72. doi: 10.1182/blood-2015-11-680744. Epub 2016 Mar 8.